AERSYMLI Trademark
AERSYMLI is a USPTO trademark filed by Sanofi Biotechnology. Status: Pending.
Prosecution Summary
Trademark Summary
The standard character mark AERSYMLI covers pharmaceutical preparations for the prevention and treatment of respiratory, inflammatory, and immunological diseases and disorders, including chronic obstructive pulmonary disease (COPD), in International Class 005, along with goods and services in Domestic Classes 006, 018, 044, 046, 051, and 052. It is owned by French corporation Sanofi Biotechnology, located at 82 Avenue Raspail, Gentilly, France 94250. The mark is registered on the Principal Register with registration number 7783988 issued May 6, 2025, following a priority claim from French application 5024842 filed January 26, 2024.
Recent Activity
Filed July 10, 2024, the application faced a suspension and office action in Septembe
Trademark Facts
| Mark | AERSYMLI |
|---|---|
| Serial Number | 98640766 |
| Status | Pending |
| Filing Date | 2024-07-10 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Sanofi Biotechnology |
| Attorney of Record | Karen Lim |
| Prosecution Events | 19 |
| Latest Event | R.PR on 2025-05-06 |
Goods & Services
Pharmaceutical preparations for the prevention and treatment of respiratory, inflammatory, and immunological diseases and disorders; pharmaceutical preparations for the prevention and treatment of chronic obstructive pulmonary disease (COPD)